Ian Tabberer, investment manager in Baillie Gifford's North American equity team, explains how a powerful US healthcare lobby will use free speech laws to protect its interests.
The connection between the path of future profit growth for listed equities within the US healthcare sector and a 2010 Supreme Court judgment in favour of free speech may appear to be a tenuous one at best. Yet the impact of the July 2010 judgment in favour of Citizens United, in which the court held that the First Amendment prohibited the government from restricting independent political expenditure by corporations and unions, could be key to deciding the shape and size of the US healthcare profit pool in the future. Combine the forces of an effective industry lobbying machine with i...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
